Following recommendations by the Advisory Council on the on the Misuse of Drugs (ACMD) to which Home Office Ministers agreed, the scheduling of the following two substances under the Misuse of Drugs Regulations 2001 will change in England, Wales and Scotland so that industrial users will need a licence:

• gamma Butyrolactone (GBL)
• 1,4Butanediol (1,4 BD / BDO)

These substances will be placed in schedule 1, resulting in the current exemption that allows them to be imported, exported, produced, supplied or possessed without a licence in defined circumstances will be abolished. The amending legislation has been laid before Parliament on the 15 to Parliamentary processes, will come into force on the 15 June 2022.

The process to apply for a UK Controlled Drugs lic December 2015 and, subject ences requires a degree of preparation and some detailed information to be provided to accompany the application as well as a site visit.

This short insight in online clinic is designed to provide further information to the licence application process regarding aspects of the process with advice and some “Do’s and Don’t’s” from representatives from the Home Office Controlled Drugs licencing unit (DCLU)

This is the latest in our ongoing series of “Online Clinics” and “Best Practice Workshops”, and an senior part of our new initiative to increase the value of membership. Watch out for other such events going forward.